NCT05723718Recruiting
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment
MalnutritiOn Assessment With biOelectrical impedaNce Analysis in gastRic Cancer patIentS Undergoing Multimodal trEatment - MOONRISE Study
Source: ClinicalTrials.gov · Last updated 13 Feb 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this single-arm prospective, multicenter, cross-sectional study is to evaluate the nutritional status and body composition on tumor regression grade with bioelectrical impedance analysis in gastric cancer patients undergoing multimodal treatment. Results of this study will reveal whether nutritional status and body composition assessment based on bioelectrical impedance analysis will become a validated and objective tool to support clinical decisions in gastric cancer patients undergoing multimodal treatment.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 125 (estimated)
- First submitted
- 24 Jan 2023
- Start date
- 20 Dec 2022
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Medical University of Lublin
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT05723718
What you commit to
- Study type: Observational
- Planned participants: 125
- From 20 Dec 2022 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Upfront surgery
Other illness
- Early gastric cancer (cT1N0-3M0) scheduled for endoscopic treatment by multidisciplinary team
- Other malignancies
- Contraindications to bioelectrical impedance analysis (e.g., implanted cardiac devices, metal implants or pregnancy)
Other
- Gastric stump carcinoma
- Distant metastasis
Who the study is looking for
- Age ≥ 18 years
- Histologically confirmed gastric adenocarcinoma (or undifferentiated carcinoma)
- Stage II - III disease (cT2 cN+ and cT3-T4 cN+/-) based on the 8th edition of TNM classification
- Qualification for multimodal treatment by the decision of the multidisciplinary tumor board
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Lublin Coordinator of this site? Confirm its status | Lublin | Poland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.